MTOR and prostate carcinoma: Our investigation uncovered the suppression of mTOR activity and Rheb expression after SMC4 knockdown, suggesting the potential role of SMC4 in governing the growth and metastasis of prostate cancer cells through the Rheb/mTOR signaling pathway.